Article
Therapeutic Suppression of Nonsense Mutation: An Emerging Target in Multiple Diseases and Thrombotic Disorders.
Current pharmaceutical design - 1 Jan 2017
Asiful Islam Md, Alam Fahmida, Kamal Mohammad Amjad, Gan Siew Hua, Wong Kah Keng, Sasongko Teguh Haryo
Abstract excerpt
Nonsense mutations contribute to approximately 10-30% of the total human inherited diseases via disruption of protein translation. If any of the three termination codons (UGA, UAG and UAA) emerges prematurely [known as premature termination codon (PTC)] before the natural canonical stop codon, truncated nonfunctional proteins or proteins with deleterious loss or gain-of-function activities are synthesized,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
